DRI Healthcare Trust (DHT.UN) Competitors

DRI Healthcare Trust logo
C$19.35 +0.24 (+1.26%)
As of 11/16/2026 04:00 PM Eastern

DHT.UN vs. CRON, MJN, CARA, GUD, and THCX

Should you buy DRI Healthcare Trust stock or one of its competitors? DRI Healthcare Trust's main competitors and comparable companies include Cronos Group (CRON), Cronos Group (MJN), Cara Operations (CARA), Knight Therapeutics (GUD), and Hydropothecary (THCX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does DRI Healthcare Trust compare to Cronos Group?

Cronos Group (TSE:CRON) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

Cronos Group has a beta of 1.196561, suggesting that its stock price is 20% more volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.087008, suggesting that its stock price is 91% less volatile than the broader market.

In the previous week, Cronos Group had 1 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for DRI Healthcare Trust. DRI Healthcare Trust's average media sentiment score of 0.50 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Neutral
DRI Healthcare Trust Positive

Cronos Group currently has a consensus target price of C$4.92, indicating a potential upside of 4.83%. DRI Healthcare Trust has a consensus target price of C$25.60, indicating a potential upside of 32.30%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, analysts plainly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

Cronos Group has a net margin of 27.93% compared to DRI Healthcare Trust's net margin of 5.02%. Cronos Group's return on equity of 5.35% beat DRI Healthcare Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group27.93% 5.35% -3.73%
DRI Healthcare Trust 5.02%2.06%4.22%

DRI Healthcare Trust has lower revenue, but higher earnings than Cronos Group. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$206.20M8.34-C$32.78MC$0.1629.31
DRI Healthcare TrustC$172.74M6.15C$9.73MC$1.0817.92

4.6% of Cronos Group shares are owned by institutional investors. Comparatively, 0.3% of DRI Healthcare Trust shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Cronos Group beats DRI Healthcare Trust on 9 of the 17 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cronos Group?

Cronos Group (CVE:MJN) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

0.3% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DRI Healthcare Trust has a net margin of 5.02% compared to Cronos Group's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos GroupN/A N/A N/A
DRI Healthcare Trust 5.02%2.06%4.22%

DRI Healthcare Trust has a consensus price target of C$25.60, indicating a potential upside of 32.30%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

Cronos Group pays an annual dividend of C$1.65 per share and has a dividend yield of 13.6%. DRI Healthcare Trust pays an annual dividend of C$0.43 per share and has a dividend yield of 2.2%. DRI Healthcare Trust pays out 39.8% of its earnings in the form of a dividend.

DRI Healthcare Trust has higher revenue and earnings than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupN/AN/AN/AN/AN/A
DRI Healthcare TrustC$172.74M6.15C$9.73MC$1.0817.92

In the previous week, DRI Healthcare Trust's average media sentiment score of 0.50 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Neutral
DRI Healthcare Trust Positive

Summary

DRI Healthcare Trust beats Cronos Group on 11 of the 13 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cara Operations?

DRI Healthcare Trust (TSE:DHT.UN) and Cara Operations (TSE:CARA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

In the previous week, DRI Healthcare Trust's average media sentiment score of 0.50 beat Cara Operations' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Cara Operations Neutral

DRI Healthcare Trust presently has a consensus target price of C$25.60, indicating a potential upside of 32.30%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, equities research analysts plainly believe DRI Healthcare Trust is more favorable than Cara Operations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

DRI Healthcare Trust has a net margin of 5.02% compared to Cara Operations' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Cara Operations' return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Cara Operations N/A N/A N/A

0.3% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

DRI Healthcare Trust has higher revenue and earnings than Cara Operations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$172.74M6.15C$9.73MC$1.0817.92
Cara OperationsN/AN/AN/AN/AN/A

DRI Healthcare Trust pays an annual dividend of C$0.43 per share and has a dividend yield of 2.2%. Cara Operations pays an annual dividend of C$0.41 per share. DRI Healthcare Trust pays out 39.8% of its earnings in the form of a dividend.

Summary

DRI Healthcare Trust beats Cara Operations on 12 of the 13 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Knight Therapeutics?

DRI Healthcare Trust (TSE:DHT.UN) and Knight Therapeutics (TSE:GUD) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

DRI Healthcare Trust has higher earnings, but lower revenue than Knight Therapeutics. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$172.74M6.15C$9.73MC$1.0817.92
Knight TherapeuticsC$563.45M2.08-C$30.73MC$0.1674.50

0.3% of DRI Healthcare Trust shares are owned by institutional investors. Comparatively, 21.1% of Knight Therapeutics shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Comparatively, 45.6% of Knight Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

DRI Healthcare Trust currently has a consensus price target of C$25.60, indicating a potential upside of 32.30%. Knight Therapeutics has a consensus price target of C$9.50, indicating a potential downside of 20.30%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, research analysts clearly believe DRI Healthcare Trust is more favorable than Knight Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Knight Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

DRI Healthcare Trust has a beta of 0.087008, meaning that its share price is 91% less volatile than the broader market. Comparatively, Knight Therapeutics has a beta of -0.507722, meaning that its share price is 151% less volatile than the broader market.

In the previous week, Knight Therapeutics had 1 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 1 mentions for Knight Therapeutics and 0 mentions for DRI Healthcare Trust. Knight Therapeutics' average media sentiment score of 0.72 beat DRI Healthcare Trust's score of 0.50 indicating that Knight Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Knight Therapeutics Positive

DRI Healthcare Trust has a net margin of 5.02% compared to Knight Therapeutics' net margin of 2.84%. DRI Healthcare Trust's return on equity of 2.06% beat Knight Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Knight Therapeutics 2.84%2.03%0.51%

Summary

DRI Healthcare Trust beats Knight Therapeutics on 11 of the 17 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Hydropothecary?

DRI Healthcare Trust (TSE:DHT.UN) and Hydropothecary (CVE:THCX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

In the previous week, DRI Healthcare Trust's average media sentiment score of 0.50 beat Hydropothecary's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Hydropothecary Neutral

DRI Healthcare Trust has higher revenue and earnings than Hydropothecary.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$172.74M6.15C$9.73MC$1.0817.92
HydropothecaryN/AN/AN/AN/AN/A

DRI Healthcare Trust has a net margin of 5.02% compared to Hydropothecary's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Hydropothecary N/A N/A N/A

0.3% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DRI Healthcare Trust presently has a consensus price target of C$25.60, indicating a potential upside of 32.30%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, equities research analysts clearly believe DRI Healthcare Trust is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

DRI Healthcare Trust beats Hydropothecary on 11 of the 11 factors compared between the two stocks.

Get DRI Healthcare Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHT.UN vs. The Competition

MetricDRI Healthcare TrustPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$1.06BC$13.69BC$7.83BC$12.83B
Dividend Yield3.22%2.58%2.46%4.65%
P/E Ratio17.9226.7133.3829.78
Price / Sales6.157.318.593.81
Price / CashN/A15.7421.9334.92
Price / Book2.085.144.403.42
Net IncomeC$9.73MC$2.88BC$3.52BC$299.09M
7 Day Performance-0.72%-3.31%-4.48%-2.27%
1 Month Performance8.22%-3.80%-3.53%-3.40%
1 Year Performance21.39%-7.24%0.12%13.64%

DRI Healthcare Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHT.UN
DRI Healthcare Trust
2.8106 of 5 stars
C$19.35
+1.3%
C$25.60
+32.3%
+20.6%C$1.06BC$172.74M17.92N/A
CRON
Cronos Group
0.9441 of 5 stars
C$4.82
flat
C$4.92
+2.0%
+35.9%C$1.77BC$206.20M30.13610
MJN
Cronos Group
N/AC$12.15
-1.9%
N/A+0.0%C$1.73BN/AN/A7,600
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/AN/A80
GUD
Knight Therapeutics
0.6557 of 5 stars
C$12.06
flat
C$9.50
-21.2%
+94.1%C$1.19BC$563.45M75.38830

Related Companies and Tools


This page (TSE:DHT.UN) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners